Loading clinical trials...
Loading clinical trials...
Development of Memesto, a Wearable Repetitive Message and Music Therapy Device That Senses and Reduces Agitation in Persons With AD/ADRD
Conditions
Interventions
Memesto
Locations
1
United States
Rush Alzheimer's Disease Center
Chicago, Illinois, United States
Start Date
August 1, 2022
Primary Completion Date
November 21, 2023
Completion Date
December 31, 2023
Last Updated
September 19, 2024
NCT07033494
NCT06159673
NCT07457138
NCT07214727
NCT07422857
NCT06584357
Lead Sponsor
Edgewater Safety Systems, Inc.
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions